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Abstract
Background: While silver nanoparticles (AgNPs) are widely used in consumer and medical products, the
mechanism by which AgNPs cause pulmonary cytotoxicity is not clear. AgNP agglomerates are found in
endo-lysosomal structures within the cytoplasm of treated cells. In this study, the functional role of lysosomes
in AgNP-induced cellular damage was examined in A549 human lung alveolar epithelial cells. We evaluated
the intracellular distribution of AgNPs, lysosomal pH, cellular viability, Ag dissolution, and metallothionein (MT)
mRNA levels in AgNP-exposed A549 cells that were treated with bafilomycin A1, the lysosomal acidification
inhibitor.
Findings: Exposure of A549 cells to citrate-coated AgNPs (20 nm diameter) for 24 h induced cellular damage
and cell death at 100 and 200 μg Ag/ml, respectively. Confocal laser microscopic examination of LysoTracker-
stained cells showed that AgNPs colocalized with lysosomes and their agglomeration increased in a dose-
dependent manner (50–200 μg Ag/ml). In addition, the fluorescence signals of LysoTracker were reduced
following exposure to AgNPs, suggesting the elevation of lysosomal pH. Treatment of A549 cells with 200 nM
bafilomycin A1 and AgNPs (50 μg Ag/ml) further reduced the fluorescence signals of LysoTracker. AgNP-
induced cell death was also increased by bafilomycin A1 treatment. Finally, treatment with bafilomycin A1
suppressed the dissolution of Ag and decreased the mRNA expression levels of MT-I and MT-II following
exposure to AgNPs.
Conclusions: The perturbation of lysosomal pH by AgNP exposure may play a role in AgNP agglomeration
and subsequent cellular damage in A549 cells.
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Background
Silver nanoparticles (AgNPs) are widely used in con-
sumer and medical products; however, much attention is
now being paid to their adverse health effects in
humans. Inhalation is considered the most important
route of exposure for nanoparticles, including AgNPs
[1]. Because repetitive inhalation of AgNPs induces pul-
monary damage in animal models [2, 3], it is important
that we clarify the mechanism underlying AgNP pul-
monary cytotoxicity.
Morphological investigations using confocal laser mi-
croscopy and transmission electron microscopy (TEM)
have shown that AgNPs are taken up by a variety of cell
types and deposited as agglomerates/aggregates in endo-
somes or lysosomes within the cytoplasm [4–8]. How-
ever, to the best of our knowledge, the toxicological
significance of lysosomal dysfunction in AgNP-exposed
lung epithelial cells has not been examined.
Lysosomes are membrane-bound organelles containing
hydrolases that function in the degradation of macro-
molecules delivered via the endocytic, phagocytic, and
autophagic pathways [9]. The lumenal environment is
maintained at a pH of 4.6–5.0 by proton-pumping
ATPase (H+-ATPase) [10]. Bafilomycin A1, a macrolide
antibiotic isolated from Streptomyces sp., is a highly
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specific inhibitor of vacuolar H+-ATPase [11]. This sub-
stance has been reported to increase lysosomal pH and
induce lysosomal dysfunction in cultured cells [12]. In
the present study, we examined the effects of bafilomy-
cin A1 treatment on cellular damage induced by citrate-
coated AgNP (20 nm diameter) exposure in A549
human lung alveolar epithelial cells. We evaluated the
intracellular distribution of AgNPs, lysosomal pH, cel-
lular viability, Ag dissolution, and expression of the
Ag+-inducible metallothionein (MT) gene in AgNP-
exposed A549 cells in the presence of bafilomycin A1.
Methods
Cell culture and treatments
A549 cells (Japan Health Sciences Foundation, Osaka,
Japan) were grown in minimum essential medium with
non-essential amino acids supplemented with 10 % heat-
inactivated fetal bovine serum, 100 U/ml penicillin, and
100 μg/ml streptomycin (GIBCO, Invitrogen Corp.,
Carlsbad, CA, USA) in a humidified atmosphere of 5 %
CO2 and 95 % air at 37 °C. Exponentially growing A549
cells were seeded on 6-well culture plates, 96-well cul-
ture plates, or Imaging Chamber CG slides and cultured
for 24 h before each experiment. Citrate-capped 20 nm
AgNPs (Citrate NanoXact™ Silver) were obtained from
nanoComposix (San Diego, CA, USA). A TEM image of
the AgNPs used is shown in Fig. 1. The particle diameter
and the zeta-potential of these AgNPs in culture
medium containing 1 % albumin were 36.6 ± 21.4 nm
(mean ± standard deviation, n = 70) and −15.4 mV, re-
spectively. Cells were exposed to the appropriate concen-
trations of well-dispersed AgNPs (50–1000 μg Ag/ml) for
24 h in 1 % albumin-containing culture medium. Bafilo-
mycin A1 (LC Laboratories, Woburn, MA, USA) was
dissolved in dimethyl sulfoxide (DMSO). Cells were incu-
bated in culture medium containing 0.4 % DMSO or 200
nM bafilomycin A1 for 24 h before treating with AgNPs
for an additional 24 h.
Cell viability
Cell viability was determined using a WST-8 cytotoxicity
assay (nacalai tesque, Kyoto, Japan), a modified MTT
assay. Ten microliters of the Cell Count Reagent SF con-
taining 5 mM WST-8 was added to each well of 96-well
culture plates. After incubating for 1 h at 37 °C, the
absorbance of each well was measured at 450 nm with a
reference wavelength of 655 nm.
Fluorescence imaging of lysosome
Cells were incubated with LysoTracker® Blue DND-22
(Life Technologies Japan Ltd., Tokyo, Japan) for 30 min
at 37 °C. After washing cells with phosphate buffer sa-
line, fluorescence images were captured using confocal
laser microscopy (LSM-710, Carl Zeiss, Jena, Germany).
Ag concentrations
Ultracentrifugation of the cellular lysate was used to
obtain the supernatant (soluble fraction) and the pellet
(insoluble fraction). The acid-digested samples were
diluted with deionized water and the concentrations of
Ag were measured by inductively coupled plasma-mass
spectrometry (Model 7500c, Agilent Technologies,
Tokyo, Japan) at m/z 107 as described previously [13].
Quantitative real-time PCR
Total RNA was isolated using the RNeasy® Plus Kit
(Qiagen Gmbh, Hilden, Germany). Aliquots of total
RNA (1 μg) were reverse-transcribed into cDNA with
the High Capacity cDNA Reverse Transcription Kits
(Life Technologies Japan Ltd.) according to the manufac-
turer’s instructions. Quantitative real-time PCR analysis
was performed using a StepOne Real-Time PCR System
and the Universal SYBR® Select Master Mix (Life
Technologies Japan Ltd.) as described previously [14].
The primer sequences were as follows: MT-I, 5’-CT
TGGGATCTCCAACCTCAC-3’ (forward) and 5’-AGG
TGCATTTGCACTCTTTG-3’ (reverse); MT-II, 5’-ATG
GATCCCAACTGCTCCT-3’ (forward) and 5’-GCATTT
GCACTCTTTGCATT-3’ (reverse); GAPDH, 5’-AATCC
CATCACCATCTTCCA-3’ (forward) and 5’-TGGACTC
CACGACGTACTCA-3’ (reverse). The expression levels
of MT-I and MT-II mRNAs were normalized to the level
of GAPDH expression.
50 nm
Fig. 1 Transmission electron microscopy image of 20 nm AgNPs.
AgNPs suspension in methanol were placed onto a collodion
membrane-attached sheet mesh (150-A) and dried at room
temperature. Scale bar, 50 nm
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Statistics
Results are expressed as mean ± standard deviation. Stat-
istical significance was determined with a one-way ana-
lysis of variance followed by the Dunnett’s multiple-
comparison test. When two groups were compared, a
Student’s t-test or Welch’s t-test was used. A value of
P < 0.05 was considered statistically significant.
Results and discussion
Exposure to AgNPs at the doses of 100 or 200 μg Ag/ml
for 24 h caused A549 cells to separate from each other
and to change from an epithelioid to a rounded shape
(Fig. 2a). This cellular damage was found to be severe at
the higher dose (200 μg Ag/ml). A WST-8 assay also
showed a decrease in cell viability at 200 μg Ag/ml and
for higher doses (Fig. 2b). We wanted to determine
whether this cellular damage is caused by the action of
AgNPs on lysosomes by using LysoTracker, a dye that
accumulates in acidic vesicles [15]. Confocal laser micro-
scopic examination of LysoTracker-stained A549 cells
showed that AgNPs colocalized with lysosomes and their
agglomeration increased in a dose-dependent manner
(50–200 μg Ag/ml) (Fig. 3). On the other hand, the
fluorescence signals of LysoTracker decreased as AgNP
dose increased. These findings demonstrated that AgNP
agglomerates accumulated in the lysosomes of lung epi-
thelial cells in agreement with data from non-pulmonary
cells exposed to AgNPs, such as human hepatoma cells
[4], mesenchymal stem cells [5], HeLa cells [6], leukemia
cells [7], and rat embryonic cells [8].
It has been proposed that AgNPs are degraded to the
Ag+ ion in the acidic lysosomal environment [16]. Our
Fig. 2 AgNP-induced cellular damage. a Phase-contrast micrographs. A549 cells were exposed to AgNPs (50–200 μg Ag/ml) for 24 h. Scale bar,
100 μm. b Cell viability. A549 cells were exposed to AgNPs (50–1000 μg Ag/ml) for 24 h. Cell viability was determined using a WST-8 assay. Each
value (mean ± standard deviation, n = 3) represents the percent survival relative to untreated control cells (0 μg Ag/ml). **P < 0.01 compared to
the control
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finding that cellular damage (Fig. 2) and AgNPs agglom-
eration were accompanied by decreased LysoTracker
staining (Fig. 3) during exposure to varying doses of
AgNPs raised the possibility that lysosomal dysfunction,
represented by lysosomal alkalization, might play a role
in AgNP cytotoxicity in A549 cells. Therefore, we exam-
ined the effects of lysosomal pH alkalization induced by
bafilomycin A1 treatment in AgNP-exposed A549 cells.
As expected, treatment of A549 cells with bafilomycin
A1 (200 nM) alone reduced LysoTracker staining. AgNP
(50 μg Ag/ml) and bafilomycin A1 treatment reduced
the fluorescence signals of LysoTracker and increased
AgNP agglomerates in A549 cells (Fig. 4). While treat-
ment with bafilomycin A1 alone did not induce cell
death, AgNP (50, 100, and 200 μg Ag/ml) treatment
combined with bafilomycin A1 treatment significantly
Fig. 3 Colocalization of AgNPs with lysosomes and perturbation of lysosomes. A549 cells were exposed to AgNPs (50–200 μg Ag/ml) for 24 h
and incubated with LysoTracker for 30 min. The lysosomes of cells were visualized by confocal laser microscopy with LysoTracker staining (green
signal). Differential interference contrast (DIC) and fluorescence images were merged (merge). Scale bar, 10 μm
Fig. 4 Effects of bafilomycin A1 treatment on AgNP-induced perturbation of lysosomes. A549 cells were incubated in culture medium with or
without 200 nM bafilomycin A1 (BFA1) for 24 h before treating with or without AgNPs (50 μg Ag/ml) for an additional 24 h. Then, cells were
incubated with LysoTracker for 30 min. The lysosomes of cells were visualized by confocal laser microscopy with LysoTracker staining (green signal).
DIC and fluorescence images were merged (merge). Scale bar, 10 μm
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reduced cell viability (Fig. 5). When compared to A549
cells exposed to AgNPs (50 μg Ag/ml) alone, the con-
centration of Ag in the soluble fraction significantly
decreased by 56 % and the concentration in the insol-
uble fraction increased by 125 % in cells treated with
bafilomycin A1 and AgNPs (Fig. 6a), suggesting a de-
crease in the degradation of AgNPs to the Ag+ ion in
lysosomes.
It has been reported that AgNPs incorporate into cells,
and the Ag+ ion induces de novo synthesis of MT-I and
MT-II [17], cytoprotective low-molecular weight pro-
teins. Treatment with bafilomycin A1 significantly de-
creased the AgNP-induced (50 μg Ag/ml) elevation of
MT-I and MT-II mRNA expression by 74 % and 61 %,
respectively (Fig. 6b). Although the mechanism under-
lying fluctuation of the acidic lysosomal environment by
AgNP exposure is not clear, our experiments using bafi-
lomycin A1 further support the possible involvement of
lysosomal dysfunction in AgNP cytotoxicity in A549
cells. In contrast to the proposed preferential role of re-
leased Ag+ ions [1, 16, 18, 19], our results suggest that
AgNP agglomerates/aggregates and other nanoparticle-
specific properties might also contribute to A549 cellular
damage.
Lysosomes are considered to be critical intracellular
organelles responsible for the cytotoxicity of nanoma-
terials [20, 21]. Similar to AgNPs, gold nanoparticles
have been reported to increase lysosomal pH and in-
duce lysosome impairment in normal rat kidney cells
[22]. Therefore, lumenal alkalization by these metallic
nanoparticles might lead to lysosomal dysfunction
with cytotoxic consequences [20]. Furthermore, a neu-
tral red assay showed lysosomal destabilization in
AgNP-exposed hepatopancreas cells from adult oys-
ters (Crassostrea virginica) [23]. Inhibition of cathep-
sin, a lysosomal protease, suppressed the release of
interleukin-1β from human blood monocytes treated
with AgNPs [24]. These findings suggest that AgNP
exposure could disrupt the lysosomal-membrane, i.e.,
lysosomal-membrane permeabilization (LMP) [25]. Partial
LMP induces apoptosis via mitochondrial outer mem-
brane permeabilization, and massive LMP induces necro-
sis via cytosolic acidification [20]. Further investigation of
lysosomal function will provide clues to understanding the
mechanisms of pulmonary damage caused by exposure to
AgNPs and other heavy metallic nanoparticles.
In summary, the present study presents data suggest-
ing that lysosomal dysfunction caused by AgNP expos-
ure may reduce pH-dependent Ag dissolution and MT
expression, resulting in the cellular damage of pulmon-
ary epithelial cells. Additional experiments, including
animal models, are needed to reveal the precise mechan-
ism of the perturbation of lysosomal function by AgNP
exposure.
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Fig. 5 Effects of bafilomycin A1 treatment on AgNP-induced cell
death. A549 cells were incubated in culture medium with or without
200 nM BFA1 for 24 h before treating with or without AgNPs
(50–200 μg Ag/ml) for an additional 24 h. Cell viability was
determined using a WST-8 assay. Each value (mean ± standard
deviation, n = 4) represents the percent survival relative to untreated
control cells (without AgNPs and BFA1). *P < 0.05, **P < 0.01 compared
to cells without BFA1 at each concentration of AgNPs
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Fig. 6 Effects of bafilomycin A1 treatment on Ag dissolution and
metallothionein expression following exposure to AgNPs. A549 cells
were incubated in culture medium with or without 200 nM BFA1 for
24 h before treating with AgNPs (50 μg Ag/ml) for an additional
24 h. a Ag concentrations in the soluble (left) and insoluble fractions
(right). Values (ng/104 cells) are mean ± standard deviation (n = 3).
b mRNA levels of MT-I (left) and MT-II (right). Total RNA was isolated
and subjected to real-time PCR analysis using MT-I or MT-II gene-
specific primers. Each value (mean ± standard deviation, n = 3) was
normalized to the GAPDH level, and the control value (cells without
BFA1 and AgNPs) was set to 1. **P < 0.01 compared to cells without
BFA1 and with AgNPs
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